BALPHARMA

Bal Pharma Share PriceBal Pharma

₹69.85
-0.6 (-0.85%)
As on 26 March, 2023 | 20:16 BSE: 524824 NSE: BALPHARMA

Bal Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Bal Pharma

Start SIP

Bal Pharma Share Price

  • Over 1 Month -4.05%
  • Over 3 Month -27.28%
  • Over 6 Month -25.17%
  • Over 1 Year -39.31%

Bal Pharma Key Statistics

P/E Ratio 34.6
PEG Ratio -0.6
Market Cap Cr 110
Price to Book Ratio 1.9
EPS 5
Dividend 1.4
Relative Strength Index 34.85
Money Flow Index 69.29
MACD Signal -2.44
Average True Range 2.54

Bal Pharma Investment Rating

  • Master Rating:
  • Bal Pharma has an operating revenue of Rs. 295.81 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 3% needs improvement, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 46%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 18 which is a POOR score indicating inconsistency in earnings, a RS Rating of 12 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Bal Pharma Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 77757074
Operating Expenses Qtr Cr 70696470
Operating Profit Qtr Cr 6653
Depreciation Qtr Cr 2222
Interest Qtr Cr 3322
Tax Qtr Cr 0000
Net Profit Qtr Cr 1113

Bal Pharma Technicals

EMA & SMA

Current Price
₹69.85
-0.6 (-0.85%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 71.99
  • 50 Day
  • 76.82
  • 100 Day
  • 82.25
  • 200 Day
  • 88.2
  • 20 Day
  • 71.14
  • 50 Day
  • 77.94
  • 100 Day
  • 84.04
  • 200 Day
  • 89.87

Bal Pharma Resistance and Support

PIVOT
₹71.
Resistance
First Resistance 71.95
Second Resistance 73.45
Third Resistance 74.41
RSI 34.85
MFI 69.3
MACD Single Line -2.44
MACD -2.15
Support
First Resistance 69.5
Second Resistance 68.55
Third Resistance 67.05

Bal Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 8,065 553,178 68.59
Week 42,738 3,904,544 91.36
1 Month 21,358 1,741,539 81.54
6 Month 33,858 1,844,900 54.49

Bal Pharma Result Highlights

Bal Pharma Synopsis

NSE-Medical-Diversified

Bal Pharma Ltd belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 280.37 Cr. and Equity Capital is Rs. 14.82 Cr. for the Year ended 31/03/2022. Bal Pharma Ltd. is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368.
Market Cap 109
Sales 295
Shares in Float 0.75
No of funds 2
Yield 1.42
Book Value 1.18
U/D Vol ratio 0.7
LTDebt / Equity 31
Alpha -0.16
Beta 0.42

Bal Pharma

Owner NameDec-22Sep-22Jun-22Apr-22
Promoters 51.61%52%52%
Foreign Portfolio Investors 0.18%0.2%0.3%
Individual Investors 32.13%31.48%31.45%
Others 16.08%16.32%16.25%

Bal Pharma Management

Name Designation
Mr. Shailesh D Siroya Managing Director
Mr. Himesh Virupakshaya Executive Director
Mr. Jatish Sheth Independent Director
Dr. C V Srinivas Independent Director
Ms. Nicloa Neeladri Independent Director
Mr. H S Venkatesh Additional Director
Mr. Kotian Chittananda Damodar Additional Director

Bal Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Bal Pharma FAQs

What is Share Price of Bal Pharma ?

Bal Pharma share price is ₹69 As on 26 March, 2023 | 20:02

What is the Market Cap of Bal Pharma ?

The Market Cap of Bal Pharma is ₹109.6 Cr As on 26 March, 2023 | 20:02

What is the P/E ratio of Bal Pharma ?

The P/E ratio of Bal Pharma is 34.6 As on 26 March, 2023 | 20:02

What is the PB ratio of Bal Pharma ?

The PB ratio of Bal Pharma is 1.9 As on 26 March, 2023 | 20:02

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number